Akero

A metabolic disease is a pathology resulting from the absence or dysfunction of certain enzymes required for reactions within our cells.

Akero focuses in particular on non-alcoholic fatty liver associated with metabolic syndrome (abdominal obesity, high cholesterol, diabetes, hypertension, etc.).

The company uses innovative approaches based in particular on gene therapies. Worldwide, the number of people suffering from non-alcoholic steatohepatitis is estimated at between 100 and 180 million.